The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-4-[(Z)-4-(4-Hexyl-phenyl)-but-1-enyl]-2-((1R,2S)-2-methyl-cyclopropyl)-4,5-dihydro-thiazole ID: ALA327770
PubChem CID: 44322989
Max Phase: Preclinical
Molecular Formula: C23H33NS
Molecular Weight: 355.59
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCCCCCc1ccc(CC/C=C\[C@@H]2CSC([C@@H]3C[C@@H]3C)=N2)cc1
Standard InChI: InChI=1S/C23H33NS/c1-3-4-5-6-9-19-12-14-20(15-13-19)10-7-8-11-21-17-25-23(24-21)22-16-18(22)2/h8,11-15,18,21-22H,3-7,9-10,16-17H2,1-2H3/b11-8-/t18-,21+,22+/m0/s1
Standard InChI Key: ZNJDFVRFRGYJEW-AUXHNBDHSA-N
Molfile:
RDKit 2D
27 29 0 0 1 0 0 0 0 0999 V2000
9.5917 -4.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0417 -5.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4917 -6.2042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7667 -4.8375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8667 -5.4667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8417 -4.0542 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.5125 -4.0542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7250 -3.8000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1875 -3.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9000 -3.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1875 -5.1250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3042 -6.5250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5542 -5.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9167 -5.7875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3625 -5.0875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1292 -6.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5750 -5.8542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4542 -4.4625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6292 -4.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8625 -7.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0375 -7.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3292 -8.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7667 -7.8500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5917 -7.8792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5042 -8.5167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4167 -6.0792 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
9.4417 -6.0875 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 2 0
5 2 1 0
6 1 1 0
7 4 1 0
7 8 1 6
9 6 1 0
10 8 2 0
11 19 1 0
12 16 1 0
13 5 1 0
14 15 1 0
15 11 2 0
16 17 2 0
17 11 1 0
18 10 1 0
19 18 1 0
20 12 1 0
21 20 1 0
22 23 1 0
23 24 1 0
24 21 1 0
25 22 1 0
5 26 1 6
2 27 1 6
7 9 1 0
3 5 1 0
12 14 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 355.59Molecular Weight (Monoisotopic): 355.2334AlogP: 6.47#Rotatable Bonds: 10Polar Surface Area: 12.36Molecular Species: NEUTRALHBA: 2HBD: ┄#RO5 Violations: 1HBA (Lipinski): 1HBD (Lipinski): ┄#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 4.44CX LogP: 7.49CX LogD: 7.49Aromatic Rings: 1Heavy Atoms: 25QED Weighted: 0.35Np Likeness Score: 1.36
References 1. Nishikawa A, Shirai R, Koiso Y, Hashimoto Y, Iwasaki S. (1997) Design and synthesis of curacin a analogs with varied side chain structures, 7 (20): [10.1016/S0960-894X(97)10055-5 ]